Fatty acid binding protein 5 inhibitors as novel anticancer agents against metastatic castration-resistant prostate cancer.
- DOI
- 10.1016/j.bmc.2025.118136
- Published
- 2025 May 1
- Container
- Bioorganic & medicinal chemistry
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1016/j.bmc.2025.118136,
title = {Fatty acid binding protein 5 inhibitors as novel anticancer agents against metastatic castration-resistant prostate cancer.},
author = {Wang H and Zhu C and Swamynathan MM and Rajput S and Jayanetti K and Rendina D and Takemura K and Bogdan D and Wang L and Rizzo RC and Kaczocha M and Trotman LC and Bialkowska AB and Ojima I},
year = {2025},
journal = {Bioorganic \& medicinal chemistry},
doi = {10.1016/j.bmc.2025.118136},
url = {https://doi.org/10.1016/j.bmc.2025.118136}
}RIS
TY - JOUR TI - Fatty acid binding protein 5 inhibitors as novel anticancer agents against metastatic castration-resistant prostate cancer. AU - Wang H AU - Zhu C AU - Swamynathan MM AU - Rajput S AU - Jayanetti K AU - Rendina D AU - Takemura K AU - Bogdan D AU - Wang L AU - Rizzo RC AU - Kaczocha M AU - Trotman LC AU - Bialkowska AB AU - Ojima I PY - 2025 JO - Bioorganic & medicinal chemistry DO - 10.1016/j.bmc.2025.118136 UR - https://doi.org/10.1016/j.bmc.2025.118136 ER -
APA
H, W., C, Z., MM, S., S, R., K, J., D, R., K, T., D, B., L, W., RC, R., M, K., LC, T., AB, B., & I, O. (2025). Fatty acid binding protein 5 inhibitors as novel anticancer agents against metastatic castration-resistant prostate cancer.. Bioorganic & medicinal chemistry. https://doi.org/10.1016/j.bmc.2025.118136
Source records
- pubmed · retrieved 2026-09-25T08:38:13.934Z